Anwar, Mohiemen
Arendt, Maja-Louise
Ramachandran, Mohanraj http://orcid.org/0000-0003-2685-0575
Carlsson, Anette
Essand, Magnus http://orcid.org/0000-0002-9725-0422
Akusjärvi, Göran
Alusi, Ghasan
Öberg, Daniel http://orcid.org/0000-0002-3934-675X
Funding for this research was provided by:
Grant by Ixogen Ltd. (private company), London, UK [Öberg-Arendt]
Grant by Ixogen Ltd. (private company), London, UK [Anwar]
Article History
Received: 4 January 2021
Revised: 28 March 2022
Accepted: 5 May 2022
First Online: 20 May 2022
Competing interests
: AC, GA, M-LA, MR and ME have no conflict of interests. DÖ and MA have both stocks in Ixogen Ltd., UK. GhA is the founder and CEO of Ixogen Ltd. Ixogen holds worldwide patents to Ixovex-1. GhA is also the founder and CEO of PsiVac Ltd., UK.
: All in vivo work was performed in accordance with the Swedish animal ethical permit C215/12, The FELASA guidelines and pre-cleared by the departmental animal ethics committee.